Drug Utilization Study on the Prescribing Indications for Yasmin® and Other OCs in Croatia

To Evaluate Compliance to Treatment Regimen (Rate of Deviations From the Prescribed Regimen) in Polish Females Treated With Different Low Dose Oral Contraceptives

NCT01198444 ·Status: COMPLETED

Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women

NCT01475513 ·Status: COMPLETED ·Phase: PHASE4

A Drug-drug Interaction Study to Investigate the Effects of AZD1981 on the Metabolism and Pharmacodynamics of Oral Contraceptives

NCT01110525 ·Status: COMPLETED ·Phase: PHASE1

Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam

NCT03353857 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Oral Contraceptive Study

NCT00185484 ·Status: COMPLETED ·Phase: PHASE3

Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325

NCT02103569 ·Status: COMPLETED ·Phase: PHASE1

Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women

NCT00651846 ·Status: COMPLETED ·Phase: PHASE4

Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases

NCT02349399 ·Status: COMPLETED

Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female Subjects

NCT02159131 ·Status: COMPLETED ·Phase: PHASE1

Risk Minimisation Study for Diane-35 and Its Generics

NCT02410031 ·Status: COMPLETED

A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood

NCT05934942 ·Status: TERMINATED ·Phase: PHASE1

Drug Interaction Oral Contraceptive Pill (OCP)

NCT01063023 ·Status: COMPLETED ·Phase: PHASE1

The Effect of Hormonal Contraception on Female

NCT01852786 ·Status: UNKNOWN

Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects

NCT00983957 ·Status: COMPLETED ·Phase: PHASE1

A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®)

NCT07181343 ·Status: COMPLETED ·Phase: PHASE1

Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone

NCT01597986 ·Status: COMPLETED ·Phase: PHASE1

Oral Contraceptive Therapy and Sexuality

NCT02613039 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females

NCT00745901 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Participants

NCT04718636 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives

NCT01291004 ·Status: COMPLETED ·Phase: PHASE1

Drug-drug Interaction of BI 201335 and Microgynon

NCT01570244 ·Status: COMPLETED ·Phase: PHASE1

Long-term Active Surveillance Study for Oral Contraceptives (LASS)

NCT00676065 ·Status: COMPLETED

Study to Investigate Efficacy and Safety of a New Oral Contraceptive

NCT00185289 ·Status: COMPLETED ·Phase: PHASE3

Oral Contraceptives in the Metabolic Syndrome

NCT00205504 ·Status: COMPLETED ·Phase: PHASE4

Yasmin 20 Cycle Control - Yasmin 20 Versus Mercilon in Healthy Female Volunteers

NCT00624130 ·Status: COMPLETED ·Phase: PHASE3